1. Home
  2. AX vs ALKS Comparison

AX vs ALKS Comparison

Compare AX & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AX
  • ALKS
  • Stock Information
  • Founded
  • AX 1999
  • ALKS 1987
  • Country
  • AX United States
  • ALKS Ireland
  • Employees
  • AX N/A
  • ALKS N/A
  • Industry
  • AX Savings Institutions
  • ALKS Biotechnology: Pharmaceutical Preparations
  • Sector
  • AX Finance
  • ALKS Health Care
  • Exchange
  • AX Nasdaq
  • ALKS Nasdaq
  • Market Cap
  • AX 5.2B
  • ALKS 5.1B
  • IPO Year
  • AX 2005
  • ALKS 1991
  • Fundamental
  • Price
  • AX $89.99
  • ALKS $29.40
  • Analyst Decision
  • AX Strong Buy
  • ALKS Strong Buy
  • Analyst Count
  • AX 7
  • ALKS 13
  • Target Price
  • AX $90.43
  • ALKS $40.38
  • AVG Volume (30 Days)
  • AX 310.3K
  • ALKS 1.3M
  • Earning Date
  • AX 10-29-2025
  • ALKS 10-23-2025
  • Dividend Yield
  • AX N/A
  • ALKS N/A
  • EPS Growth
  • AX N/A
  • ALKS 21.99
  • EPS
  • AX 7.43
  • ALKS 2.08
  • Revenue
  • AX $1,203,093,000.00
  • ALKS $1,505,296,000.00
  • Revenue This Year
  • AX $12.79
  • ALKS N/A
  • Revenue Next Year
  • AX $7.59
  • ALKS $1.66
  • P/E Ratio
  • AX $12.12
  • ALKS $14.18
  • Revenue Growth
  • AX 13.59
  • ALKS N/A
  • 52 Week Low
  • AX $54.46
  • ALKS $25.56
  • 52 Week High
  • AX $92.99
  • ALKS $36.45
  • Technical
  • Relative Strength Index (RSI)
  • AX 58.78
  • ALKS 58.29
  • Support Level
  • AX $89.71
  • ALKS $28.77
  • Resistance Level
  • AX $92.99
  • ALKS $29.39
  • Average True Range (ATR)
  • AX 1.65
  • ALKS 0.69
  • MACD
  • AX 0.08
  • ALKS 0.13
  • Stochastic Oscillator
  • AX 59.62
  • ALKS 77.14

About AX Axos Financial Inc.

Axos Financial Inc is a bank holding company that operates through its bank subsidiary, BofI Federal Bank, a nationwide bank that provides financing for single and multifamily residential properties, small to medium-size businesses in certain sectors, and selected specialty finance receivables. Its operating segments are banking business segment and securities business segment. The bank distributed its products through a wide range of retail distribution channels, including only banking brands, affinity groups, and sales teams, among others. The majority of the bank's mortgage exposure is titled toward the state of California, particularly its southern region. Net interest income is a majority of the bank's revenue.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: